Parabilis Soared Biggest Biotech: Is It Too Late to Buy?
A record biotech IPO backdrop has investors buzzing about Parabilis Medicines. This guide breaks down what the surge ...
Young professionals can benefit from targeted wealth growth tips. Learn how to maximize your earnings and investments.
22,851 articlesA record biotech IPO backdrop has investors buzzing about Parabilis Medicines. This guide breaks down what the surge ...
Bitcoin climbs as a tentative Iran peace framework sparks risk-on buying. Japan's ETF market shows steady inflows, wh...
As the chip index climbs, fund managers sit on a cautious chair, weighing gains against risk. Bank of America flags p...
The first half of 2026 delivered a housing market that steadied into a new normal. Here are the five lessons that def...
Investors chase international dividend income, but IDV's 6-7% yield sits beside volatile cycles in oil, banks, and mi...
A SpaceX IPO could ripple across tech and autos. This guide explains how spacex should help rivian through AI compute...
Regulators move away from wallet limits and toward a per product ceiling for sterling tokens, setting the stage for a...
J.P. Morgan's strategists raise their year-end S&P 500 view to 7,800, citing stronger earnings and resilient consumer...
Gold and mining stocks have faced heightened volatility. This week, eldorado gold stock diving has sparked questions ...
Anthropic accuses Alibaba of distillation tactics to train rival systems, prompting fresh worries about frontier AI m...
Honeywell Aerospace begins trading as an independent company with a clear capital-allocation rule: invest in the supp...
Oklo is developing compact nuclear reactors geared for AI data centers. This article lays out a grounded five-year ro...